vimarsana.com
Home
Live Updates
Roivant Reports Positive Topline Results from ADORING 1, the Second Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as 2 Years Old : vimarsana.com
Roivant Reports Positive Topline Results from ADORING 1, the Second Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% in Adults and Children as Young as 2 Years Old
ADORING 1 met the primary and all secondary endpoints, consistent with the positive topline results from the Phase 3 ADORING 2 trial reported in March, marking Roivant’s 10th consecutive... | May 16, 2023
Related Keywords
,
Eli Lilly ,
Stephanie Lee ,
Twitter ,
Exchange Commission ,
Dermavant Sciences ,
Dermavant Sciences Gmb ,
Roivant Sciences ,
Roivant Sciences Forward ,
Iqvia National Prescription Audit ,
Pabout Roivant Sciences ,
Dermavant Sciences Inc ,
Linkedin Dermavant Sciences ,
Securities Exchange ,
Securities Act ,
Securities Exchange Act ,
Risk Factors ,
Adverse Events ,
Prescribing Information ,
Atopic Dermatitis ,
All Rights ,
Prescription Audit ,
Roivant Sciences Ltd Stock Exchange ,
News ,
Information ,
Press Release ,
Adoring ,
Pet ,
The ,
Primary ,
End ,
Wall ,
Secondary ,
Consistent ,
Ith ,
Positive ,
Topline ,
Results ,
Rom ,
Hase ,
Trial ,
Eported ,
N ,
Parking ,
0th Roiv Bmg762791017 ,
vimarsana.com © 2020. All Rights Reserved.